Johnson & Johnson (BVMF:JNJB34)

Market Cap	2.52T
Revenue (ttm)	496.48B
Net Income (ttm)	124.14B
Shares Out	n/a
EPS (ttm)	51.13
PE Ratio	20.27
Forward PE	17.45
Dividend	1.28 (1.88%)
Ex-Dividend Date	Aug 26, 2025

Volume	3,045
Average Volume	3,491
Open	67.66
Previous Close	67.42
Day's Range	67.23 - 68.58
52-Week Range	54.62 - 68.08
Beta	0.39
RSI	73.01
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: JNJB34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD